Skip to main content
Top
Published in: International Journal of Mental Health Systems 1/2015

Open Access 01-12-2015 | Case study

Delayed identification and diagnosis of Huntington’s disease due to psychiatric symptoms

Authors: Alina Mihaela Pascu, Petru Ifteni, Andreea Teodorescu, Victoria Burtea, Christoph U. Correll

Published in: International Journal of Mental Health Systems | Issue 1/2015

Login to get access

Abstract

Huntington’s disease (HD) is a progressive neurodegenerative illness that affects 2–9/100.000 of the general population. The usual onset is at around age 35–40 years, but there were cases with onset above 55 years. The disease manifests clinically with many neurological and psychiatric symptoms, leading in advanced phases to dementia, but cognitive symptoms are frequently present much earlier in the disease course. HD is caused by an expanded polyglutamine stretch in the N-terminal part of a 350 kDa protein called huntingtin (HTT). This stretch is encoded by a trinucleotide CAG repetition in exon 1 of HTT. An expansion of greater than 36 repeats results in HD. The number of repeats is inversely correlated with the age of onset of motor symptoms, and disease onset during childhood or adolescence is associated with more than 60 CAG repeats. Mood disturbances may be one of the earliest symptoms of HD and may precede the onset of the motor pheno-type for almost 10 years. Neuropsychiatric symptoms may delay the appropriate diagnosis of HD and have major implications for disease management, prognosis and quality of life for patients and families. This case study is about a 58 years old female patient with late identification of Huntington’s disease after two admissions to psychiatric inpatient units, for the treatment of behavioral disturbances.
Literature
2.
go back to reference Novak MJ, Tabrizi SJ. Huntington’s disease: clinical presentation and treatment. Int Rev Neurobiol. 2011;98:297–323.CrossRefPubMed Novak MJ, Tabrizi SJ. Huntington’s disease: clinical presentation and treatment. Int Rev Neurobiol. 2011;98:297–323.CrossRefPubMed
4.
go back to reference Huntington Collaborative Research Group. A novel gene containing a trin- ucleotide that is expanded and unstable on huntington’s disease chromosomes. Cell. 1993;72:971–83.CrossRef Huntington Collaborative Research Group. A novel gene containing a trin- ucleotide that is expanded and unstable on huntington’s disease chromosomes. Cell. 1993;72:971–83.CrossRef
6.
go back to reference Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006;311:864–8.CrossRefPubMed Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006;311:864–8.CrossRefPubMed
7.
go back to reference Craufurd D, Thompson JC, Snowden JS. Behavioral change in Huntington disease. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14:219–26.PubMed Craufurd D, Thompson JC, Snowden JS. Behavioral change in Huntington disease. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14:219–26.PubMed
8.
go back to reference Kingma EM, van Duijn E, Timman R, van der Mast RC, Roos RAC. Behavioral problems in Huntington’s disease using the problem behaviors assessment. Gen Hosp Psychiatry. 2008;30:155–61.CrossRefPubMed Kingma EM, van Duijn E, Timman R, van der Mast RC, Roos RAC. Behavioral problems in Huntington’s disease using the problem behaviors assessment. Gen Hosp Psychiatry. 2008;30:155–61.CrossRefPubMed
9.
go back to reference Nopoulos PC, Aylward EH, Ross CA, et al. Smaller intracranial volume in prodromal Huntington’s disease: evidence for abnormal neurodevelopment. Brain. 2011;134(Pt 1):137–42.PubMedCentralCrossRefPubMed Nopoulos PC, Aylward EH, Ross CA, et al. Smaller intracranial volume in prodromal Huntington’s disease: evidence for abnormal neurodevelopment. Brain. 2011;134(Pt 1):137–42.PubMedCentralCrossRefPubMed
10.
go back to reference Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL. Neuropsychiatric aspects of Huntington’s disease. J Neurol Neurosurg Psychiatry. 2001;71(3):310–4.PubMedCentralCrossRefPubMed Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL. Neuropsychiatric aspects of Huntington’s disease. J Neurol Neurosurg Psychiatry. 2001;71(3):310–4.PubMedCentralCrossRefPubMed
11.
go back to reference Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N. The incidence and prevalence of Huntington’s disease: a systematic review and meta-analysis. Mov Disord. 2012;27(9):1083–91.CrossRefPubMed Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N. The incidence and prevalence of Huntington’s disease: a systematic review and meta-analysis. Mov Disord. 2012;27(9):1083–91.CrossRefPubMed
12.
go back to reference Sitek EJ, Thompson JC, Craufurd D, Snowden JS. Unawareness of deficits in Huntington’s disease. J Huntingtons Dis. 2014;3(2):125–35.PubMed Sitek EJ, Thompson JC, Craufurd D, Snowden JS. Unawareness of deficits in Huntington’s disease. J Huntingtons Dis. 2014;3(2):125–35.PubMed
13.
go back to reference Zielonka D, Marinus J, De Roos RAC, Michele G, Di Donato S, Putter H, Marcinkowski J, Squitieri F, Bentivoglio AR, Landwehrmeyer GB. The influence of gender on phenotype and disease progression in patients with Huntington’s disease. Parkinsonism Relat Disord. 2013;19(2):192–7.CrossRefPubMed Zielonka D, Marinus J, De Roos RAC, Michele G, Di Donato S, Putter H, Marcinkowski J, Squitieri F, Bentivoglio AR, Landwehrmeyer GB. The influence of gender on phenotype and disease progression in patients with Huntington’s disease. Parkinsonism Relat Disord. 2013;19(2):192–7.CrossRefPubMed
14.
go back to reference Myers RH, Sax DS, Schoenfeld M, Bird ED, Wolf PA, Vonsattel JP, White RF, Martin JB. Late onset of Huntington’s disease. J Neurol Neurosurg Psychiatry. 1985;48(6):530–4.PubMedCentralCrossRefPubMed Myers RH, Sax DS, Schoenfeld M, Bird ED, Wolf PA, Vonsattel JP, White RF, Martin JB. Late onset of Huntington’s disease. J Neurol Neurosurg Psychiatry. 1985;48(6):530–4.PubMedCentralCrossRefPubMed
15.
go back to reference Wheeler VC, Persichetti F, McNeil SM, Mysore JS, Mysore SS, MacDonald ME, Myers RH, Gusella JF, Wexler NS, US-Venezuela Collaborative Research Group. Factors associated with HD CAG repeat instability in Huntington disease. J Med Genet. 2007;44(11):695–701.PubMedCentralCrossRefPubMed Wheeler VC, Persichetti F, McNeil SM, Mysore JS, Mysore SS, MacDonald ME, Myers RH, Gusella JF, Wexler NS, US-Venezuela Collaborative Research Group. Factors associated with HD CAG repeat instability in Huntington disease. J Med Genet. 2007;44(11):695–701.PubMedCentralCrossRefPubMed
16.
go back to reference Berrios GE, Wagle AC, Marková IS, Wagle SA, Ho LW, Rubinsztein DC, Whittaker J, Ffrench-Constant C, Kershaw A, Rosser A, Bak T, Hodges JR. Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington’s disease gene carriers. Psychiatry Res. 2001;102(3):217–25.CrossRefPubMed Berrios GE, Wagle AC, Marková IS, Wagle SA, Ho LW, Rubinsztein DC, Whittaker J, Ffrench-Constant C, Kershaw A, Rosser A, Bak T, Hodges JR. Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington’s disease gene carriers. Psychiatry Res. 2001;102(3):217–25.CrossRefPubMed
17.
go back to reference van Duijn E, Kingma EM, Timman R, Zitman FG, Tibben A, Roos RA, van der Mast RCJ. Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington’s disease compared with mutation-negative first-degree relatives. Clin Psychiatry. 2008;69(11):1804–10.CrossRef van Duijn E, Kingma EM, Timman R, Zitman FG, Tibben A, Roos RA, van der Mast RCJ. Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington’s disease compared with mutation-negative first-degree relatives. Clin Psychiatry. 2008;69(11):1804–10.CrossRef
18.
go back to reference Smith JA, Michie S, Stephenson M, Quarrell O. Risk perception and decision-making processes in candidates for genetic testing for Huntington’s disease: an interpretive phenomenological analysis. J Health Psychol. 2002;7(2):131–44.CrossRefPubMed Smith JA, Michie S, Stephenson M, Quarrell O. Risk perception and decision-making processes in candidates for genetic testing for Huntington’s disease: an interpretive phenomenological analysis. J Health Psychol. 2002;7(2):131–44.CrossRefPubMed
Metadata
Title
Delayed identification and diagnosis of Huntington’s disease due to psychiatric symptoms
Authors
Alina Mihaela Pascu
Petru Ifteni
Andreea Teodorescu
Victoria Burtea
Christoph U. Correll
Publication date
01-12-2015
Publisher
BioMed Central
Published in
International Journal of Mental Health Systems / Issue 1/2015
Electronic ISSN: 1752-4458
DOI
https://doi.org/10.1186/s13033-015-0026-6

Other articles of this Issue 1/2015

International Journal of Mental Health Systems 1/2015 Go to the issue